Tacrolimus effect on rosacea.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 14699377.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twenty-four patients with erythrotelangiectatic or papulopustular rosacea were treated with 0.1% tacrolimus topical ointment in a 12-week open-label trial. Erythema was significantly improved in both rosacea subtypes (P<.05). There was no decrease in the number of papulopustular lesions. Side effects were consistent with those on the tacrolimus topical ointment labeling.
Medical subject headings
- Immunosuppressive Agents
- Rosacea
- Tacrolimus